Search research articles
Contact Us
Filters
Showing results (11-20 of 127) with videos related to
Page
of 13
Sort By:
Expert Review of Endocrinology & Metabolism
|
February 14, 2019
Bone mineral density and vitamin D in PCOS and hirsutism
Dorte Glintborg, Anne Pernille Hermann, Marianne Andersen
American Journal of Physiology. Endocrinology and Metabolism
|
July 27, 2006
Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study
Thue Kvorning, Marianne Andersen, Kim Brixen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 13, 2004
[Changes in reporting on passive smoking by parents of small children]
Karl Erik Lund, Asgeir R Helgason, Marianne Andersen
Endocrine Connections
|
April 23, 2017
Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
Dorte Glintborg, Hanne Mumm, Jens Juul Holst, et al.
Fertility and Sterility
|
October 11, 2011
Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome
Line Velling Magnussen, Hanne Mumm, Marianne Andersen, et al.
Clinical Endocrinology
|
June 10, 2005
Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism
Dorte Glintborg, Marianne Andersen, Claus Hagen, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
April 17, 2018
Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome
Magda Lambaa Altinok, Pernille Ravn, Marianne Andersen, et al.
Clinical Endocrinology
|
January 28, 2009
Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment
Dorte Glintborg, Marianne Andersen, Bjørn Richelsen, et al.
Clinical Endocrinology
|
October 19, 2007
A 12-month randomized crossover study on the effects of lanreotide Autogel and octreotide long-acting repeatable on GH and IGF-l in patients with acromegaly
Magdalene Andries, Dorte Glintborg, Annette Kvistborg, et al.
Clinical Endocrinology
|
September 18, 2010
Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark
Dorte Glintborg, Hanne Mumm, David Hougaard, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 127) with videos related to
Sort By:
Page
of 13
Expert Review of Endocrinology & Metabolism
|
February 14, 2019
Bone mineral density and vitamin D in PCOS and hirsutism
Dorte Glintborg, Anne Pernille Hermann, Marianne Andersen
American Journal of Physiology. Endocrinology and Metabolism
|
July 27, 2006
Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study
Thue Kvorning, Marianne Andersen, Kim Brixen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
January 13, 2004
[Changes in reporting on passive smoking by parents of small children]
Karl Erik Lund, Asgeir R Helgason, Marianne Andersen
Endocrine Connections
|
April 23, 2017
Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
Dorte Glintborg, Hanne Mumm, Jens Juul Holst, et al.
Fertility and Sterility
|
October 11, 2011
Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome
Line Velling Magnussen, Hanne Mumm, Marianne Andersen, et al.
Clinical Endocrinology
|
June 10, 2005
Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism
Dorte Glintborg, Marianne Andersen, Claus Hagen, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
April 17, 2018
Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome
Magda Lambaa Altinok, Pernille Ravn, Marianne Andersen, et al.
Clinical Endocrinology
|
January 28, 2009
Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment
Dorte Glintborg, Marianne Andersen, Bjørn Richelsen, et al.
Clinical Endocrinology
|
October 19, 2007
A 12-month randomized crossover study on the effects of lanreotide Autogel and octreotide long-acting repeatable on GH and IGF-l in patients with acromegaly
Magdalene Andries, Dorte Glintborg, Annette Kvistborg, et al.
Clinical Endocrinology
|
September 18, 2010
Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark
Dorte Glintborg, Hanne Mumm, David Hougaard, et al.
Page
of 13